MILTENYI BIOTEC LIMITEDActive

Company number 03096272Private limited companyIncorporated 1995

Key figures

£3,876,617+167.5%
Net assets 2025
+36.5%
Average annual growth 2023–2025
01 m2 m3 m4 m202320242025

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m15 m202320242025

Dividends

from the accounts
2023

Dividends paid in the financial year: £2,100,000 (216% of the profit for the year).

Filed accounts2023–2025
202320242025
Turnover29,158,38935,152,11046,047,168
Profit for the year970,0382,368,5702,427,208
Cash at bank and in hand2,519,4213,499,2974,739,495
Total assets7,396,61910,014,61312,097,575
Total liabilities———
Net assets / total equity2,080,8391,449,4093,876,617
Average number of employees675757
Average pay (per year)74,41684,16893,223
Dividends paid2,100,000——

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MILTENYI BIOTEC LIMITED

Company

MILTENYI BIOTEC LIMITED is a private limited company registered with Companies House under company number 03096272. It was incorporated on 30 Aug 1995. Its status is active. The registered office is in Woking (GU24). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100), other human health activities (86900).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files medium company accounts. Turnover was £46,047,168. Profit for the year was £2,427,208. Net assets were £3,876,617, up 167.5% on the previous year. Cash at bank and in hand was £4,739,495. The company had an average of 57 employees. Figures are available for 3 financial years (2023–2025).

Control and charges

One person with significant control is registered. 3 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 13 Sep 2027.